H.C. Wainwright Sticks With Buy on Coya Therapeutics, $18 Target After Private Placement
H.C. Wainwright has reaffirmed a Buy rating and an $18.00 price target on Coya Therapeutics (NASDAQ:COYA) after the company completed a private placement that generated roughly $11.1 million in gross proceeds. The analyst house views the financing as extending Coya’s operational runway into late 2027 and highlights investor support from Dr. Reddy’s…